CAS 910562-15-1

Simenepag

CAS: 910562-15-1

Simenepag is a drug that belongs to the class of anti-glaucoma drugs. It lowers intraocular pressure by reducing the production of aqueous humor and has been shown to be effective in combination with other drugs in the treatment of glaucoma. Simenepag has also been shown to have prophylactic properties, as it prevents the development of hypertension. The drug's main target is hydroxystearate, which is an enzyme involved in the synthesis of prostaglandins. This is achieved by inhibiting its activity or preventing it from binding with arachidonic acid. Simenepag targets prostaglandin synthesis by inhibiting enzymes that are involved in the metabolism of arachidonic acid. This prevents the formation of inflammatory mediators such as prostaglandins and leukotrienes, which are responsible for many diseases including hypertension, glaucoma, and disorders associated with pain sensation.

Formula: C₂₃H₂₉NO₅S

Purezza: Min. 95%

Peso molecolare: 431.5 g/mol

Ref: 3D-KLB56215

AGN 210676

CAS: 910562-15-1

AGN 210676 is a selective agonist of prostaglandin EP2(EC50 : 5 nM).

Formula: C₂₃H₂₉NO₅S

Purezza: 98%

Colore e forma: Solid

Peso molecolare: 431.55

Ref: TM-T14146